Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure
Article 2022 en
Authors
SC
Sergio Caravita
AF
Andrea Faini
CV
Carlo Vignati
Abstract
1 min read
Intravenous ferric carboxymaltose improves the hypercapnic ventilatory response and sleep-related breathing disorders in patients with heart failure, anaemia and iron deficiency. These newly described findings, along with improved oxygen delivery to exercising muscles, likely contribute to the favourable effects of ferric carboxymaltose in anaemic patients with heart failure.
Fozia Ahmed, Paul R. Kalra, John G.F. Cleland, Abdallah Al‐Mohammad, Andrew L. Clark, Victor Chong, Alan G. Japp, Rebecca Lane, Stephen J Leslie, Iain C. Macdougall, Thuraia Nageh, Rajiv Sankaranarayanan, Jolanta Sobolewska, Aaron Wong, Elizabeth Thomson, Mark C. Petrie, Iain Squire, Ian Ford, Philip A. Kalra
Jessica E. Ringshaw, Michal R. Zieff, Sadeeka Williams, Chloë A. Jacobs, Zayaan Goolam Nabi, Thandeka Mazubane, Marlie Miles, Donna Herr, Daniel C. Alexander, Melissa Gladstone, Vanja Klepac‐Ceraj, Laurel J. Gabard‐Durnam, Dima Amso, William P. Fifer, Derek K. Jones, Dan Joseph Stein, S. C. Williams, Kirsten A. Donald
Discussion(0)
No comments yet. Be the first to comment.